u/Away_Cancel_5208 · 23d ago1 prior · awaiting results
Long BNTX $100C exp Jun 18
BNTX is about to go full send at ASCO and nobody’s talking about it 🚀🧬
BioNTech will present multiple late-stage clinical readouts at ASCO 2026 starting May 29th, with pumitamig (PD-L1 + VEGF-A bispecific) potentially rivaling Keytruda in lung cancer. Positive Phase 2 data would unlock a multi-product oncology empire narrative and phase in $16.8B cash runway, driving upside.
At post $88.85Now $86.15-3.0% since postedas of Jun 10, 4:59 PM ET
1d-1.2%
3d+2.3%
1w+3.7%
1m—
3m—
6m—
1y—